Method for screening tumor specificity target and targeting ligand based on tissue chip

A tumor-specific tissue chip technology, applied in biochemical equipment and methods, microbial assay/inspection, measurement devices, etc., can solve the large gap between the screening system and the tumor living environment, and the low versatility of drugs or targeted therapy , small screening throughput and other issues, to achieve the effect of high versatility, strong comparability, and simple verification methods

Inactive Publication Date: 2012-05-23
BEIJING UNIV OF TECH
View PDF3 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] The purpose of the present invention is to overcome the disadvantages in the prior art of low versatility of drugs or targeted therapy, large gap between the screening system and the living environment of tumors in vivo, small screening throughput, time-consuming and laborious, and provide a tissue chip-based tumor-specific Screening methods for sexual targets and targeting ligands

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for screening tumor specificity target and targeting ligand based on tissue chip
  • Method for screening tumor specificity target and targeting ligand based on tissue chip
  • Method for screening tumor specificity target and targeting ligand based on tissue chip

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0037] I. Materials

[0038] Ph.D.-7 TM Phage Display Peptide Library Kit was purchased from New England Biolabs (Beijing) Co.Ltd; lung squamous cell carcinoma (moderately differentiated) tissue chip CS04-03-001, lung normal tissue (multiple parts) tissue chip NC04-01-001 and The CS04-03-002 used in the verification test was purchased from Shaanxi Chaoying Biotechnology Co., Ltd. IPTG is packaged for Merck, X-gal is packaged for BDX, and PEG-8000 is packaged for Amersco.

[0039] The determination of the random phage sequence was completed by Shanghai Sangong Technology Co., Ltd.; the HRP-Anti-M13 monoclonal antibody used in immunohistochemistry was purchased from GE, blocking serum, DAB color development kit, and hematoxylin counterstaining solution were purchased from Zhongshan Jinqiao company.

[0040] Some other conventional reagents and materials used can refer to those listed in "Molecular Cloning: A Laboratory Guide", and will not be described in detail here.

[004...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention which belongs to the biotechnological field concretely relates to a method for screening a tumor specificity target and a targeting ligand with a tissue chip. The invention which aims to overcome disadvantages of low medicine or targeting treatment versatility, large gap between a screening system and in-vivo living environment of a tumor, small screening throughout, and time and labor consumption existing in the prior art provides a method for screening the tumor specificity target and the targeting ligand with the tissue chip. The targeting ligand screened in the invention has the advantages of high specificity, realization of tumor cell penetrating, no immunization reaction causing, and high versatility. The screening method maintains the original state of the in-vivo grown tumor; and compared with tumor-bearing mouse screening systems, the screening method has the advantages of animal breeding step omitting, time, labor saving and cost saving, and strong experiment result comparability. Compared with traditional screening systems, the screening method of the invention allows the tumor specificity target analysis and the targeting research to be simultaneously carried out, and the verification process is simple.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a method for screening tumor-specific targets and targeting ligands based on tissue chips. Background technique [0002] Tumor has become one of the intractable diseases that seriously threaten human health, and is surpassing cardiovascular disease to become the number one cause of death for human beings. The traditional treatment methods for tumors are mainly surgery, radiotherapy and chemotherapy. In addition to resecting and destroying tumor tissues, these treatment methods also cause great damage to normal tissues and cells due to their non-targeting. [0003] Targeted therapy is an important progress in the field of modern tumor therapy. On the basis of tumor molecular cell biology, it uses specific structural molecules possessed by tumor tissues or cells as targets, and uses certain drugs that can specifically bind to these target molecules. Antibodies, ligands, e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/574C12Q1/68
Inventor 马雪梅赵岭张记军冯娟钟儒刚
Owner BEIJING UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products